• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[麻黄,从膳食补充剂到滥用药物]

[Ma Huang, from dietary supplement to abuse].

作者信息

Arditti J, Bourdon J H, Spadari M, de Haro L, Richard N, Valli M

机构信息

Hôpital Salvator, Laboratoire de Toxicologie Centre antipoison 249 boulevard de Sainte Marguerite-13009 Marseille.

出版信息

Acta Clin Belg. 2002;57 Suppl 1:34-6.

PMID:11974441
Abstract

Dietary supplements containing Ma Huang (chinease ephedra) are available on the web sites and dietary shops in USA. They are widely promoted and used as a mean of weight reduction and energy enhancement. They contain Ma Huang alone or combined with Guarana (caffeine), creatine, St John's wort, carnitine and are proposed with different labels. Numerous reports of adverse reactions and acute intoxication related to these products use were described in the medical literature. In the light of the severity of these cases, some of which resulted in permanent injury and death, the Food and Drug Administration has proposed limits on the dose and duration of use of such supplements. A review of 140 reports submitted to the FDA between June 1997 and March 1999, 47% involved cardiovascular symptoms, 18% neurological symptoms. Severe hypertension was the single most frequent adverse effect followed by tachycardia, myocardial infarction, stroke, seizure. Ten events resulted in death and 13 produced permanent impairment. In France, ampleness of the use of dietary supplements containing ephedra alkaloids is unknown. Two French recent severe poisonings (one with "ripped Fuel" for losing weight and the other with "Energy pills" in a body builder) show that there is serious health risks for the chronic users. Dietary supplements are not subject to control under "la Direction Générale de la Santé". Informations for general public, medical community and health-care authorities are necessary to be aware of potential health hazards of these products use.

摘要

含麻黄(中国麻黄)的膳食补充剂在美国的网站和膳食商店有售。它们被广泛推广并用作减肥和增强能量的手段。它们单独含有麻黄,或与瓜拉那(咖啡因)、肌酸、圣约翰草、肉碱混合,并带有不同的标签。医学文献中描述了许多与这些产品使用相关的不良反应和急性中毒报告。鉴于这些病例的严重性,其中一些导致了永久性损伤和死亡,美国食品药品监督管理局已提议限制此类补充剂的使用剂量和使用期限。对1997年6月至1999年3月提交给美国食品药品监督管理局的140份报告进行的审查显示,47%涉及心血管症状,18%涉及神经症状。严重高血压是最常见的单一不良反应,其次是心动过速、心肌梗死、中风、癫痫发作。有10起事件导致死亡,13起造成永久性损伤。在法国,含麻黄生物碱的膳食补充剂的使用范围尚不清楚。法国最近发生的两起严重中毒事件(一起是一名减肥者服用“撕裂燃料”,另一起是一名健美运动员服用“能量丸”)表明,长期使用者存在严重的健康风险。膳食补充剂不在“法国卫生总局”的监管范围内。有必要向公众、医学界和卫生保健当局提供信息,使他们了解使用这些产品可能存在的健康危害。

相似文献

1
[Ma Huang, from dietary supplement to abuse].[麻黄,从膳食补充剂到滥用药物]
Acta Clin Belg. 2002;57 Suppl 1:34-6.
2
Ma Huang, du complement alimentaire a l'abus.
Acta Clin Belg. 2002;57 Suppl 1:34-6. doi: 10.1179/acb.2002.074.
3
Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.与含有麻黄生物碱的膳食补充剂相关的不良心血管和中枢神经系统事件。
N Engl J Med. 2000 Dec 21;343(25):1833-8. doi: 10.1056/NEJM200012213432502.
4
Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements.商业膳食补充剂中麻黄生物碱和咖啡因的含量
J Anal Toxicol. 2004 Apr;28(3):145-51. doi: 10.1093/jat/28.3.145.
5
Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine.与麻黄(一种麻黄碱草药来源)在时间上相关的不良心血管事件。
Mayo Clin Proc. 2002 Jan;77(1):12-6. doi: 10.4065/77.1.12.
6
Ephedra-containing dietary supplements in the US versus ephedra as a Chinese medicine.美国含麻黄的膳食补充剂与作为中药的麻黄
Am J Chin Med. 2004;32(1):1-10. doi: 10.1142/S0192415X04001680.
7
Cardiovascular effects of ephedra alkaloids: a comprehensive review.麻黄生物碱的心血管效应:全面综述
Prog Cardiovasc Dis. 2005 Jan-Feb;47(4):217-25. doi: 10.1016/j.pcad.2004.07.006.
8
Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial.用于减肥的草药麻黄/咖啡因:一项为期6个月的随机安全性和有效性试验。
Int J Obes Relat Metab Disord. 2002 May;26(5):593-604. doi: 10.1038/sj.ijo.0802023.
9
Psychiatric symptoms associated with ephedra use.与麻黄使用相关的精神症状。
Expert Opin Drug Saf. 2005 Sep;4(5):879-84. doi: 10.1517/14740338.4.5.879.
10
Coronary artery aneurysm and thrombosis following chronic ephedra use.长期使用麻黄素后出现冠状动脉瘤和血栓。
Int J Cardiol. 2010 Feb 18;139(1):e11-3. doi: 10.1016/j.ijcard.2008.06.081. Epub 2008 Aug 20.